To what extent the test will improve outcomes and save lives is not clear, however, as there is no effective treatment for pre-eclampsia, which usually eases after birth.
“We don’t have a therapy that reverses or cures pre-eclampsia other than delivery of the baby, which is more like a last resort,” Dr. Woelkers said.
The new blood test, made by Thermo Fisher Scientific, has been available in Europe for several years.
It is intended for pregnant women who are hospitalized for a blood pressure disorder in the 23rd to 35th weeks of gestation.
“A lot of women will have edema and headaches.” (Edema means swelling.)
Persons:
“, Woelkers, ”, Sarosh Rana
Organizations:
Fisher, University of Chicago
Locations:
Europe